Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response

BACKGROUND: Everolimus is a potential alternative to embolization and nephrectomy for managing tuberous sclerosis complex (TSC)-associated renal angiomyolipoma (AML). In 2016, National Health Service England approved its use through regional centres for renal AML ≥30 mm showing interval growth. Evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Noelle K X, Metherall, Peter, McCormick, Janet A, Simms, Roslyn J, Ong, Albert C M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214570/
https://www.ncbi.nlm.nih.gov/pubmed/35754971
http://dx.doi.org/10.1093/ckj/sfac037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214570/
https://www.ncbi.nlm.nih.gov/pubmed/35754971
http://dx.doi.org/10.1093/ckj/sfac037

Ejemplares similares